TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ESPR

Esperion Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.20$ +0.0% vs. previous close Closing price · As of: Jul 15, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ESPR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.96 -1.73 -2.12 -5.49 -5.56 -2.60 -3.10 -9.13 -2.63 -1.31 -0.13 -0.06
0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.00 0.00 0.00
0.22 0.58 0.71 0.78 0.90 0.96 1.03 0.84 0.23 0.12 0.06 0.05
0.23 0.58 0.71 0.78 0.90 0.96 1.03 0.75 0.23 – – –
0.02 -0.09 0.44 0.69 1.09 -0.27 -0.16 -1.82 -0.05 0.13 -0.32 -0.07
0.05 0.01 0.00 0.00 0.01 0.04 0.49 0.00 0.00 0.00 0.00 0.00
-2.24 -7.27 0.45 -1.50 5.25 2.37 0.78 -1.75 0.12 0.41 0.00 0.00
0.00 0.00 0.00 0.00 – – 11.02 0.00 0.00 0.00 0.00 0.00
5.63 8.68 0.00 6.90 0.44 0.43 -2.00 7.70 1.37 – – –
0.30 -0.03 -0.07 -0.07 -0.04 10.34 8.21 -0.02 0.00 0.00 0.19 -0.26
5.93 8.65 -0.07 6.83 0.40 5.03 7.34 9.28 0.49 0.49 0.46 0.17
1.74 -0.35 -1.74 -0.15 0.09 4.80 5.02 -1.59 -2.02 -0.41 0.33 0.11
-2.01 -1.75 -2.12 -5.49 -5.56 -2.63 -3.59 -9.13 -2.63 -1.31 -0.13 -0.06

Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?